Literature DB >> 24757519

An update on vaccines against Shigella.

Shai Ashkenazi1, Dani Cohen2.   

Abstract

Despite intensive research efforts for more than 60 years, utilizing diverse vaccine strategies, a safe and efficacious vaccine against shigellosis is not available yet. We are currently witnessing innovative approaches based on elucidation of the virulence mechanisms of Shigella, understanding the immune response to the pathogen and progress in molecular technology for developing Shigella vaccines. It is hoped that these will lead to a licensed effective Shigella vaccine to protect humans against the significant worldwide morbidity and mortality caused by this microorganism.

Entities:  

Keywords:  Shigellosis; diarrhea; gastroenteritis; prevention; vaccine

Year:  2013        PMID： 24757519      PMCID： PMC3967666          DOI： 10.1177/2051013613500428

Source DB:  PubMed          Journal:  Ther Adv Vaccines        ISSN： 2051-0136


  78 in total

Review 1.  Systematic review: the epidemiology and clinical features of travellers' diarrhoea.

Authors:  H L DuPont
Journal:  Aliment Pharmacol Ther       Date:  2009-04-21       Impact factor: 8.171

2.  Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.

Authors:  Edwin V Oaks; K Ross Turbyfill
Journal:  Vaccine       Date:  2005-12-05       Impact factor: 3.641

3.  Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults.

Authors:  L F Fries; A D Montemarano; C P Mallett; D N Taylor; T L Hale; G H Lowell
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

4.  Shigella infection in breast-fed Guatemalan indian neonates.

Authors:  L J Mata; J J Urrutia; B García; R Fernández; M Béhar
Journal:  Am J Dis Child       Date:  1969-02

5.  Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population.

Authors:  D Cohen; M S Green; C Block; T Rouach; I Ofek
Journal:  J Infect Dis       Date:  1988-05       Impact factor: 5.226

6.  Vaccine strain Sh. flexneri T32-Istrati. Studies in animals and in volunteers. Antidysentery immunoprophylaxis and immunotherapy by live vaccine Vadizen (Sh. flexneri T32-Istrati).

Authors:  T Meitert; E Pencu; L Ciudin; M Tonciu
Journal:  Arch Roum Pathol Exp Microbiol       Date:  1984 Jul-Dec

Review 7.  Shigella infections in children: new insights.

Authors:  Shai Ashkenazi
Journal:  Semin Pediatr Infect Dis       Date:  2004-10

Review 8.  Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine.

Authors:  Myron M Levine
Journal:  BMC Biol       Date:  2010-10-04       Impact factor: 7.431

9.  Protection against local Shigella sonnei infection in mice by parenteral immunization with a nucleoprotein subcellular vaccine.

Authors:  V J Levenson; C P Mallett; T L Hale
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

10.  Safety and immunogenicity of CVD 1208S, a live, oral DeltaguaBA Deltasen Deltaset Shigella flexneri 2a vaccine grown on animal-free media.

Authors:  Karen L Kotloff; Jakub K Simon; Marcela F Pasetti; Marcelo B Sztein; Stacey L Wooden; Sofie Livio; James P Nataro; William C Blackwelder; Eileen M Barry; Wendy Picking; Myron M Levine
Journal:  Hum Vaccin       Date:  2007-07-15
View more
  18 in total

1.  A novel protein-based subunit Shigella vaccine candidate.

Authors:  Malabi M Venkatesan
Journal:  Immunol Cell Biol       Date:  2015-06-09       Impact factor: 5.126

Review 2.  Shigella flexneri: an emerging pathogen.

Authors:  Iqbal Nisa; Muhammad Qasim; Nusrat Yasin; Rafi Ullah; Anwar Ali
Journal:  Folia Microbiol (Praha)       Date:  2020-02-05       Impact factor: 2.099

Review 3.  A tale of two bacterial enteropathogens and one multivalent vaccine.

Authors:  Eileen M Barry; Myron M Levine
Journal:  Cell Microbiol       Date:  2019-07-10       Impact factor: 3.715

Review 4.  Serum IgG antibodies to Shigella lipopolysaccharide antigens - a correlate of protection against shigellosis.

Authors:  Dani Cohen; Shiri Meron-Sudai; Anya Bialik; Valeria Asato; Sophy Goren; Ortal Ariel-Cohen; Arava Reizis; Amit Hochberg; Shai Ashkenazi
Journal:  Hum Vaccin Immunother       Date:  2019-05-09       Impact factor: 3.452

5.  PCR-Based Method for Shigella flexneri Serotyping: International Multicenter Validation.

Authors:  Silvina P Brengi; Qiangzheng Sun; Hilda Bolaños; Francisco Duarte; Claire Jenkins; Mariana Pichel; Mohammad Shahnaij; Evangeline G Sowers; Nancy Strockbine; Kaisar A Talukder; Gordana Derado; María Rosa Viñas; Kai Man Kam; Jianguo Xu
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948

Review 6.  Combination vaccines against diarrheal diseases.

Authors:  Malabi M Venkatesan; Lillian L Van de Verg
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 7.  Pinus Species as Prospective Reserves of Bioactive Compounds with Potential Use in Functional Food-Current State of Knowledge.

Authors:  Marcin Dziedziński; Joanna Kobus-Cisowska; Barbara Stachowiak
Journal:  Plants (Basel)       Date:  2021-06-28

8.  Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB.

Authors:  Christiane Gerke; Anna Maria Colucci; Carlo Giannelli; Silvia Sanzone; Claudia Giorgina Vitali; Luigi Sollai; Omar Rossi; Laura B Martin; Jochen Auerbach; Vito Di Cioccio; Allan Saul
Journal:  PLoS One       Date:  2015-08-06       Impact factor: 3.240

9.  An attenuated Shigella mutant lacking the RNA-binding protein Hfq provides cross-protection against Shigella strains of broad serotype.

Authors:  Jiro Mitobe; Ritam Sinha; Soma Mitra; Dhrubajyoti Nag; Noriko Saito; Ken Shimuta; Nobuo Koizumi; Hemanta Koley
Journal:  PLoS Negl Trop Dis       Date:  2017-07-20

10.  An H-NS Family Protein, Sfh, Regulates Acid Resistance by Inhibition of Glutamate Decarboxylase Expression in Shigella flexneri 2457T.

Authors:  Chang Niu; Dongshu Wang; Xiaoqing Liu; Hongsheng Liu; Xiankai Liu; Erling Feng; Chao Pan; Ruifeng Wang; Wei Xiao; Xingming Liu; Xinrui Liu; Li Zhu; Hengliang Wang
Journal:  Front Microbiol       Date:  2017-10-05       Impact factor: 5.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.